Xilio Therapeutics (XLO) Stock Chart & Stock Price History → How to Play the AI and Crypto Markets in One Swing (From Weiss Ratings) (Ad) Free XLO Stock Alerts $1.12 +0.03 (+2.75%) (As of 05/15/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Xilio Therapeutics Stock Price Performance5 Day Performance-5.08%1 Month Performance-11.11%3 Month Performance+90.67%6 Month Performance-16.42%Year-To-Date Performance+103.64%1 Year Performance-63.52% Receive XLO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Xilio Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. XLO Stock Chart for Wednesday, May, 15, 2024 XLO Chart by TradingView Xilio Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/15/2024$1.09$1.12+2.75%$1.15$1.09117,733 shs$41.34 million05/14/2024$1.12$1.09-2.68%$1.14$1.06125,352 shs$40.23 million05/13/2024$1.18$1.12-5.08%$1.18$1.01273,595 shs$41.34 million05/10/2024$1.26$1.18-6.35%$1.30$1.11229,366 shs$43.55 million05/09/2024$1.21$1.26+4.13%$1.32$1.16216,726 shs$46.51 million05/08/2024$1.26$1.21-3.97%$1.29$1.16157,661 shs$44.66 million Get the Latest News and Ratings for XLO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Xilio Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/07/2024$1.25$1.26+0.80%$1.29$1.2598,764 shs$46.51 million05/06/2024$1.18$1.25+5.93%$1.28$1.18284,729 shs$46.14 million05/03/2024$1.05$1.18+12.38%$1.22$1.04265,011 shs$43.55 million05/02/2024$1.08$1.05-2.78%$1.12$1.04182,804 shs$38.76 million05/01/2024$1.04$1.08+3.85%$1.13$1.01225,276 shs$39.86 million04/30/2024$1.04$1.04$1.08$1.01100,113 shs$38.39 million04/29/2024$1.09$1.04-4.59%$1.15$1.01377,744 shs$38.39 million04/26/2024$1.01$1.09+7.92%$1.11$1.02143,939 shs$37.57 million04/25/2024$1.06$1.01-4.72%$1.08$0.95239,349 shs$34.82 million04/24/2024$1.05$1.06+0.95%$1.11$1.01297,031 shs$36.54 million04/23/2024$1.10$1.05-4.55%$1.15$1.01445,863 shs$36.19 million04/22/2024$1.15$1.10-4.35%$1.18$1.05254,313 shs$37.92 million04/19/2024$1.28$1.15-10.16%$1.28$1.12338,694 shs$39.64 million04/18/2024$1.23$1.28+4.07%$1.28$1.20153,082 shs$44.13 million04/17/2024$1.30$1.23-5.38%$1.34$1.22437,407 shs$42.40 million04/16/2024$1.26$1.30+3.17%$1.38$1.22324,519 shs$44.81 million04/15/2024$1.18$1.26+6.78%$1.29$1.19268,617 shs$43.43 million04/12/2024$1.36$1.18-13.24%$1.34$1.18499,960 shs$40.68 million04/11/2024$1.28$1.36+6.25%$1.40$1.26391,248 shs$46.88 million04/10/2024$1.31$1.28-2.29%$1.36$1.27413,402 shs$44.12 million04/09/2024$1.47$1.31-10.88%$1.49$1.31409,377 shs$45.16 million04/08/2024$1.20$1.47+22.50%$1.55$1.161.73 million shs$50.68 million04/05/2024$1.21$1.20-0.83%$1.30$1.14673,578 shs$41.36 million04/04/2024$1.30$1.21-6.92%$1.34$1.18844,045 shs$33.41 million04/03/2024$1.48$1.30-12.16%$1.47$1.112.29 million shs$35.89 million04/02/2024$1.53$1.48-3.27%$1.61$1.333.01 million shs$40.76 million04/01/2024$1.08$1.53+41.67%$1.63$1.1421.13 million shs$42.14 million03/29/2024$1.08$1.08$1.93$1.0534.54 million shs$29.75 million03/28/2024$0.64$1.08+69.01%$1.93$1.0634.38 million shs$29.74 million03/27/2024$0.66$0.64-3.08%$0.67$0.58174,118 shs$17.60 million03/26/2024$0.70$0.66-5.80%$0.71$0.6481,052 shs$18.16 million03/25/2024$0.71$0.70-1.07%$0.71$0.6748,616 shs$19.28 million03/22/2024$0.70$0.71+0.71%$0.74$0.65114,405 shs$19.49 million03/21/2024$0.69$0.70+1.66%$0.75$0.7066,397 shs$19.35 millionThis unknown company solves the biggest issue with AI (Ad)Nvidia is the 800-lb gorilla in AI chips. But… it has a big problem. That's where one tiny company comes in. Discover why this company03/20/2024$0.69$0.69+0.88%$0.73$0.6824,219 shs$19.03 million03/19/2024$0.68$0.69+0.93%$0.73$0.6546,684 shs$18.87 million03/18/2024$0.69$0.68-0.92%$0.72$0.6486,392 shs$18.69 million03/15/2024$0.65$0.69+5.94%$0.69$0.6385,834 shs$18.87 million03/14/2024$0.70$0.65-7.63%$0.76$0.61244,360 shs$17.81 million03/13/2024$0.67$0.70+4.40%$0.72$0.65172,647 shs$19.28 million03/12/2024$0.76$0.67-11.40%$0.79$0.65398,129 shs$18.47 million03/11/2024$0.83$0.76-8.82%$0.85$0.70362,279 shs$20.84 million03/08/2024$0.80$0.83+3.88%$0.89$0.7868,824 shs$22.86 million03/07/2024$0.82$0.80-2.56%$0.91$0.77410,043 shs$22.00 million03/06/2024$0.79$0.82+3.25%$0.91$0.79239,402 shs$22.58 million03/05/2024$0.73$0.79+8.81%$0.81$0.71139,911 shs$21.87 million03/04/2024$0.72$0.73+1.32%$0.79$0.70159,521 shs$20.10 million03/01/2024$0.71$0.72+1.61%$0.85$0.72563,010 shs$19.84 million02/29/2024$0.66$0.71+7.42%$0.78$0.66351,383 shs$19.53 million02/28/2024$0.63$0.66+5.60%$0.70$0.64328,002 shs$18.18 million02/27/2024$0.60$0.63+4.17%$0.63$0.61402,542 shs$17.21 million02/26/2024$0.58$0.60+3.08%$0.63$0.55129,286 shs$16.52 million02/23/2024$0.55$0.58+5.84%$0.59$0.5733,038 shs$16.03 million02/22/2024$0.57$0.55-3.47%$0.60$0.5385,993 shs$15.15 million02/21/2024$0.55$0.57+3.39%$0.60$0.5677,346 shs$15.69 million02/20/2024$0.61$0.55-9.80%$0.62$0.54128,194 shs$15.18 million02/19/2024$0.61$0.61$0.63$0.55130,600 shs$16.83 million02/16/2024$0.59$0.61+4.02%$0.63$0.55130,565 shs$16.83 million02/15/2024$0.60$0.59-2.10%$0.60$0.53179,756 shs$16.18 million02/14/2024$0.63$0.60-4.73%$0.66$0.50150,851 shs$16.52 million Related Companies: IMRX Stock Chart NBRV Stock Chart SNSE Stock Chart RMTI Stock Chart HCWB Stock Chart LEXX Stock Chart NXTC Stock Chart UNCY Stock Chart OCUP Stock Chart CARA Stock Chart Receive XLO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Xilio Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:XLO) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAmazon's betting big on this unknown AI companyManward PressWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingProtect Your Bank Account Before It’s Too LateWeiss RatingsGold Set to EXPLODE!Gold Safe Exchange"The Biggest Drug Ever" Is ComingBehind the MarketsThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xilio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.